Advertisement

Topics

Prolifix Limited Company Profile

12:33 EDT 26th September 2017 | BioPortfolio

Prolifix is a pharmaceutical research and development company whose objective is the discovery and development of novel therapeutics for the treatment of proliferative diseases.

The Company was initially set up to exploit scientific discoveries made at the Medical Research Council (MRC) laboratories at Mill Hill, London, relating to the control of cell division. These discoveries could lead to new treatments for diseases which involve uncontrolled cell division, such as cancer. Prolifix holds intellectual property and proprietary technologies to support its drug discovery activities.



Prolifix has since formed several additional scientific collaborations which gives it unrivalled access to research in the field of cell cycle control. The Company has entered into agreements with leading European research groups working in this area.

Location

91 Milton Park
Oxford
Oxfordshire
OX14 4RY
United Kingdom

Contact

Phone: 44 (0)1235 443737
Fax: 44 (0)1235 443744
Email: s.eccles@prolifix.co.uk


News Articles [13 Associated News Articles listed on BioPortfolio]

Quotient Limited to Participate in the UBS Global Healthcare Conference

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 Global Healthcare Conference

JERSEY, Channel Islands, May 31, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive O...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

Quotient Limited to Report Fourth Quarter and Fiscal Year 2017 Financial Results and Host Conference Call

JERSEY, Channel Islands, May 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and ...

Quotient Limited Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results

Initial MosaiQ manufacturing system commissioned and validatedFirst “commercially ready” MosaiQ Instrument delivered to QuotientInternal validation of MosaiQ underway, with EU field trials expe...

Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies

Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Prolifix Limited

Prolifix is a pharmaceutical research and development company whose objective is the discovery and development of novel therapeutics for the treatment of proliferative diseases.The Company was initial...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Prolifix Limited" on BioPortfolio

We have published hundreds of Prolifix Limited news stories on BioPortfolio along with dozens of Prolifix Limited Clinical Trials and PubMed Articles about Prolifix Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prolifix Limited Companies in our database. You can also find out about relevant Prolifix Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record